Relative change in myositis outcome measures over 6 months in patients with physician-reported change
| Outcome measures . | Median (IQR) . |
|---|---|
| Relative change in HHD, % | 20.7 (5.1 to 71.9) |
| Relative change in physician global disease activity, % | −58.3 (−77.8 to −36) |
| Relative change in MMT, % | 6.6 (0 to 13) |
| Relative change in HAQ-DI, % | −26.1 (−58.5 to 0) |
| Relative change in patient global disease activity, % | −13.3 (−40.6 to 10.9) |
| Relative change in CK, % | −28.3 (−69.5 to 25.4) |
| Relative change in SF-36 physical function, % | 69.3 (6.4 to 200) |
| Relative change in STS, % | 21.4 (8.3 to 50) |
| Relative change in TUG, % | −17 (−20.7 to −3.1) |
| Relative change in 6MWD, % | 8.7 (0.2 to 37.9) |
| Total improvement score, % | 45 (25 to 60) |
| Outcome measures . | Median (IQR) . |
|---|---|
| Relative change in HHD, % | 20.7 (5.1 to 71.9) |
| Relative change in physician global disease activity, % | −58.3 (−77.8 to −36) |
| Relative change in MMT, % | 6.6 (0 to 13) |
| Relative change in HAQ-DI, % | −26.1 (−58.5 to 0) |
| Relative change in patient global disease activity, % | −13.3 (−40.6 to 10.9) |
| Relative change in CK, % | −28.3 (−69.5 to 25.4) |
| Relative change in SF-36 physical function, % | 69.3 (6.4 to 200) |
| Relative change in STS, % | 21.4 (8.3 to 50) |
| Relative change in TUG, % | −17 (−20.7 to −3.1) |
| Relative change in 6MWD, % | 8.7 (0.2 to 37.9) |
| Total improvement score, % | 45 (25 to 60) |
SF-36: 36-item Short Form Health Survey.
Relative change in myositis outcome measures over 6 months in patients with physician-reported change
| Outcome measures . | Median (IQR) . |
|---|---|
| Relative change in HHD, % | 20.7 (5.1 to 71.9) |
| Relative change in physician global disease activity, % | −58.3 (−77.8 to −36) |
| Relative change in MMT, % | 6.6 (0 to 13) |
| Relative change in HAQ-DI, % | −26.1 (−58.5 to 0) |
| Relative change in patient global disease activity, % | −13.3 (−40.6 to 10.9) |
| Relative change in CK, % | −28.3 (−69.5 to 25.4) |
| Relative change in SF-36 physical function, % | 69.3 (6.4 to 200) |
| Relative change in STS, % | 21.4 (8.3 to 50) |
| Relative change in TUG, % | −17 (−20.7 to −3.1) |
| Relative change in 6MWD, % | 8.7 (0.2 to 37.9) |
| Total improvement score, % | 45 (25 to 60) |
| Outcome measures . | Median (IQR) . |
|---|---|
| Relative change in HHD, % | 20.7 (5.1 to 71.9) |
| Relative change in physician global disease activity, % | −58.3 (−77.8 to −36) |
| Relative change in MMT, % | 6.6 (0 to 13) |
| Relative change in HAQ-DI, % | −26.1 (−58.5 to 0) |
| Relative change in patient global disease activity, % | −13.3 (−40.6 to 10.9) |
| Relative change in CK, % | −28.3 (−69.5 to 25.4) |
| Relative change in SF-36 physical function, % | 69.3 (6.4 to 200) |
| Relative change in STS, % | 21.4 (8.3 to 50) |
| Relative change in TUG, % | −17 (−20.7 to −3.1) |
| Relative change in 6MWD, % | 8.7 (0.2 to 37.9) |
| Total improvement score, % | 45 (25 to 60) |
SF-36: 36-item Short Form Health Survey.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
